Royal Philips, a leader in health technology, has launched a new cardiac care platform aimed at transforming diagnostic cardiology in Europe, the Middle East, and Africa. The Philips Cardiac Workstation utilises sophisticated algorithms to expedite the collection and processing of electrocardiograph (ECG) data, potentially streamlining care and helping to prioritise high-risk patients.
A groundbreaking study involving over 17,000 patients has demonstrated the safety of pulsed field ablation (PFA) for treating atrial fibrillation. The MANIFEST-17K trial, led by researchers from the Icahn School of Medicine at Mount Sinai, provides compelling evidence that this novel technique avoids many of the complications associated with traditional thermal ablation methods.
A comprehensive study published in The BMJ [1] reveals a complex picture of cardiovascular disease (CVD) trends in the UK over the past two decades. While rates of coronary heart disease have declined significantly, this progress has been offset by rising incidences of other cardiovascular conditions.
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com
PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.
